West Pharmaceutical Services Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
West Pharmaceutical Services, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.892.952.892.832.151.841.72
Cost of Revenue1.891.821.751.661.381.231.17
Gross Profit1.001.131.141.180.770.610.55
Operating Expenses
Research & Development0.070.070.060.050.050.040.04
Selling, General & Administrative0.340.350.320.360.300.270.26
Operating Expenses0.410.420.350.420.350.310.30
Operating Income0.590.710.730.760.420.300.24
Other Income/Expense
Interest Income0.020.030.010.000.000.000.00
Interest Expense0.000.01-0.010.01-0.010.000.01
Other Income/Expense-0.02-0.03-0.080.00-0.02-0.010.00
Income
Income Before Tax0.590.700.680.750.420.300.24
Income Tax Expense0.110.120.110.110.070.060.04
Net Income0.490.590.590.660.350.240.21
Net Income - Continuous Operations0.490.590.590.660.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.740.840.810.880.530.410.35
EBIT0.590.710.690.760.420.310.25
Depreciation & Amortization0.160.140.120.120.11-0.100.00
Earnings Per Share
Basic EPS7.008.008.009.005.003.003.00
Diluted EPS7.008.008.009.005.003.003.00
Basic Shares Outstanding0.070.070.070.070.070.070.07
Diluted Shares Outstanding0.070.080.080.080.080.080.08